US EditionGenomics and AI set to transform rare disease diagnosis and therapeutics
Summary by Express Healthcare
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Genomics and AI set to transform rare disease diagnosis and therapeutics
Dr Rahila Sardar, Co-founder and CEO, Vgenomics India talks about the role of AI and genomics in diagnosing the rare diseases More than 350 million people worldwide suffer from over 7,000 rare diseases (RDs). If all rare diseases patients lived in one country, it would be the world’s 3rd most populous country. Approximately 80 percent of rare diseases are genetic, emphasising the role of genetic testing for accurate diagnosis. Rare diseases pose…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
